ACADIA Pharmaceuticals, Inc.

NASDAQ: ACAD
$46.09
-$0.78 (-1.7%)
Closing price February 14, 2020

Top Analyst Upgrades and Downgrades: Adobe, Amgen, BofA, Broadcom, CME, Goldman Sachs, Micron, PepsiCo, UnitedHealth, Urban Outfitters, Vertex and More

Stocks hit all-time highs last week and a phase-one trade deal with China has been announced without details, and stocks were indicated to post a marginally higher opening price on ...
Read Full Story »

Thursday’s Biggest Biotech Movers

Thursday was a breakout day for a few biotech companies. Some made absolutely massive runs, while others fell off a cliff. The biotechnology sector is pushing near all-time highs, and ...
Read Full Story »

Major Biopharma Catalysts on the December FDA Calendar

Companies in the biotech and pharmaceutical industries are subject to a sizable amount of risk with regards to their drug candidates passing clinical trials and gaining regulatory approval. But with ...
Read Full Story »

Why Parkinson’s Patients Should Be Optimistic About Acadia’s Study

Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) shares made a handy gain on Monday after the firm announced positive results from an eight-week Phase 2 study evaluating pimavanserin as a therapy for ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Acadia Pharma, Broadcom, CBOE, Etsy, Gap, GE, Home Depot, Lowe’s, Oracle, Slack and More

Stocks were indicated to open higher on Friday morning, for more than a week's worth of gains. The S&P 500 was also zeroing in on new highs. Despite all the ...
Read Full Story »

Why This New Dementia Study Is a Huge Hit

Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) shares rose sharply early Monday after the firm announced that its late-stage dementia study met its primary endpoint. Specifically, the results come from Acadia’s Phase ...
Read Full Story »

Is Acadia Pharma’s Schizophrenia Treatment Done For?

Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) shares dropped on Tuesday after the firm announced results from its late-stage study for the treatment of adult schizophrenia patients with persistent inadequate response to ...
Read Full Story »

Acadia Pharma Slides Despite Positive Major Depressive Disorder Results

Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) shares dipped on Wednesday despite the announcement of positive top-line results from its Clarity midstage study in major depressive disorder (MDD). In the trial, pimavanserin ...
Read Full Story »

What the FDA Has to Say About Acadia Pharma’s Parkinson’s Treatment

Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) shares made a handy gain to close out the week after the company announced that the U.S. Food and Drug Administration (FDA) completed a post-marketing ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AMD, Alcoa, AT&T, Darden, Micron, New Age Beverages, Nike, Novavax, Pier 1, Under Armour and More

Stocks were indicated marginally higher on Friday, but this as after the Dow Jones industrials and S&P 500 hit all-time high closes on Thursday. International markets were also higher on ...
Read Full Story »

Merrill Lynch Sees 4 Top Biotechs With Key Catalysts in 2018

Biotechnology companies offer big risk, but big reward as well. These are seen as some of the more speculative companies in the market because a single clinical trial could either ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Aetna, Analog Devices, Lowe’s, Merck, Pfizer, Plug Power, Qualcomm, Target and More

Stocks were indicated to open lower on Thursday morning, though the S&P 500 hit an all-time high earlier in the week. Earnings season is all but over now and was ...
Read Full Story »

Coty, e.l.f Beauty Sink into Thursday’s 52-Week Low Club

August 9, 2018: Here are four stocks trading with heavy volume among 96 equities making new 52-week lows in Thursday's session. On the NYSE decliners and advancers traded even and ...
Read Full Story »

6 Stocks Defying the Bull Market With Multiple Analyst Downgrades and Price Target Cuts

The morning roll call of analyst upgrades and downgrades included about 20 companies this Thursday. There are many companies that are falling outside of the strong trends of this earnings ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Applied Materials, Extreme Networks, Mylan, NXP, Roku, Seagate, Yelp, Zynga and More

Stocks were indicated to open marginally higher after a weaker producer price index report calmed some inflation fears. Earnings season has been quite strong, with more than 70% of the ...
Read Full Story »